论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
Authors Yu TT, Zhang T, Lu X, Wang RZ
Received 31 March 2018
Accepted for publication 20 July 2018
Published 10 August 2018 Volume 2018:11 Pages 4693—4700
DOI https://doi.org/10.2147/OTT.S169811
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 4
Editor who approved publication: Dr Samir Farghaly
Background: Lung adenocarcinoma is the most common pathological type of lung cancer.
However, the mechanisms underlying its development are still poorly understood.
B7-H3 was discovered as a new member of the B7 costimulatory family.
Methods: We detected the expression status of B7-H3 protein in lung
adenocarcinoma tissues, and evaluated the relationship of B7-H3 expression and
patients’ prognosis. Then, we silenced its expression in A549 cells by
transient siRNA transfection to ascertain the function of B7-H3 in lung
adenocarcinoma cells. Western blotting was used to detect the expression of
epithelial–mesenchymal transition (EMT) related proteins.
Results: We found that B7-H3 overexpressed in lung adenocarcinoma. It is
correlated with lymph node metastasis, distant metastasis, and disease stage.
The Cox regression analysis showed that B7-H3 might serve as an independent
prognostic marker of lung adenocarcinoma. We also found that B7-H3 promoted
proliferation, invasion and migration of A549 cells in vitro. B7-H3 also could
promote EMT progression by regulating EMT-related molecules.
Conclusion: B7-H3 is a potential target for the treatment of lung
adenocarcinoma.
Keywords: lung adenocarcinoma, B7-H3, epithelial–mesenchymal transition,
metastasis, proliferation